Statistics

Total Visits

Views
First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER2-negative or recurrent mBC: First PFS analysis.8

Select a period of time:

Number of views in the range

Views
First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER2-negative or recurrent mBC: First PFS analysis.7

Views

Views
November 20230
December 20231
January 20241
February 20240
March 20242
April 20241
May 20242
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
 

Top cities views

Views
Boardman2
Fort Worth1